Industry Update: Eli Lilly to Acquire Orna Therapeutics to Advance Cell Therapies
Industry Update: Providence Therapeutics Commences mRNA PCV Trial in Australia for Brain Cancers
Industry Update: CREATE Medicines Demonstrates B-Cell Depletion & Repeatable Dosing with In Vivo CAR-T
Industry Update: NeuCyte & Grann Pharma Enter Partnership for mRNA-Based Therapies for Rare Neurological Diseases
Industry Update: Adjuva Bio Awarded CELLSCRIPT™ 2026 mRNA Research Grant to Enhance Next-Gen In Vivo Cell Therapies

Engineering Next Generation mRNA-Based Therapeutic Proteins to Advance Infectious & Rare Disease Therapy Portfolios

By | 16 February 2026

Providing an overview of the mRNA platform
Case Study Presentation: mRNA encoded IgGs/VHHs for the treatment of infectious diseases
Case Study Presentation: Engineering next generation cas9 proteins to advance rare disease therapies